ODAIA has officially entered the omnichannel marketing orchestration space, unveiling a solution designed to transform how pharmaceutical brand teams engage with healthcare professionals (HCPs). This expansion complements ODAIA Field, enabling life sciences organizations to leverage AI-driven tools for personalized, real-time engagement across marketing and sales.

The company has also launched an early access program for pharma companies to test these capabilities and offer feedback, marking a major step forward in delivering unified, data-driven HCP engagement strategies.

Capabilities of ODAIA’s New Omnichannel Solution

1. Personalization at Scale Through AI

• MAPTUAL, ODAIA’s flagship platform, rapidly processes HCP and patient data to generate real-time predictive insights.

• Enables tailored campaign sequencing by determining the optimal channel, message, content type, and engagement timing for each HCP.

• Early users of MAPTUAL have seen a 7–14% increase in new patient starts.

2. Unified Marketing and Sales Coordination

• The new capabilities enable seamless two-way coordination between marketing campaigns and sales rep visits.

• Replaces siloed strategies with a synchronized engagement model that enhances both digital and in-person touchpoints.

• Each HCP interaction is guided by dynamic insights, delivering a cohesive brand experience.

3. Data-Driven Decision Making

• Moves beyond manual persona segmentation and rule-based campaign planning.

• Uses de-identified patient data and real-time behavioral signals to continuously update and refine marketing strategies.

• Adapts to competitive shifts and market dynamics faster than traditional approaches.

4. Enhanced Activation and Automation

• Integrates directly with CRMs, media platforms, and agencies to streamline campaign deployment.

• Automates channel selection, messaging, and cadence based on HCP preferences and outcomes.

• Performance data feeds back into the system, optimizing future interactions automatically.

Strategic Impact on Pharma Marketing

1. Addressing Industry Gaps

• Current strategies fail to resonate: 80% of pharma executives are satisfied with engagement efforts, but only 35% of HCPs agree.

• ODAIA bridges this disconnect with insights that target individual physician behaviors and preferences.

2. Maximizing Limited Resources

• As pharma budgets tighten and field teams shrink, maximizing the impact of every HCP interaction becomes critical.

• ODAIA ensures every outreach is personalized, timely, and effective—even with limited access to HCPs.

3. Capturing a Growing Market Opportunity

• The global omnichannel pharma marketing market is valued at up to $8 billion.

• ODAIA’s new solution positions the company as a key player in helping brands deliver compliant, personalized engagement at scale.

ODAIA’s launch into omnichannel marketing orchestration is a decisive move toward reshaping HCP engagement. By combining AI, automation, and real-time insights, ODAIA empowers pharma marketers to break away from generic campaigns and embrace a dynamic, unified strategy. As the early access program opens, pharma companies have the opportunity to participate in shaping the future of commercial excellence—one tailored HCP interaction at a time.